Your browser doesn't support javascript.
loading
Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure.
Kozhuharov, Nikola; Martin, Jasmin; Wussler, Desiree; Lopez-Ayala, Pedro; Belkin, Maria; Strebel, Ivo; Flores, Dayana; Diebold, Matthias; Shrestha, Samyut; Nowak, Albina; Gualandro, Danielle M; Michou, Eleni; Zimmermann, Tobias; Rentsch, Katharina; von Eckardstein, Arnold; Keller, Dagmar I; Breidthardt, Tobias; Mueller, Christian.
Afiliación
  • Kozhuharov N; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Martin J; Department of Cardiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
  • Wussler D; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Lopez-Ayala P; Department of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Belkin M; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Strebel I; Department of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Flores D; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Diebold M; Department of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Shrestha S; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Nowak A; Department of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Gualandro DM; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Michou E; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Zimmermann T; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Rentsch K; Department of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
  • von Eckardstein A; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Keller DI; Department of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Breidthardt T; Department of Endocrinology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
  • Mueller C; Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
Eur J Heart Fail ; 24(9): 1545-1554, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35851710
ABSTRACT

AIMS:

Obese patients have lower natriuretic peptide concentrations. We hypothesized that adjusting the concentration of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for obesity could further increase its clinical utility in the early diagnosis of acute heart failure (AHF). METHODS AND

RESULTS:

This hypothesis was tested in a prospective diagnostic study enrolling unselected patients presenting to the emergency department with acute dyspnoea. Two independent cardiologists/internists centrally adjudicated the final diagnosis using all individual patient information including cardiac imaging. NT-proBNP plasma concentrations were applied first, using currently recommended cut-offs; second, using cut-offs lowered by 33% with body mass index (BMI) of 30-34.9 kg/m2 and by 50% with BMI ≥ 35 kg/m2 . Among 2038 patients, 509 (25%) were obese, of which 271 (53%) had AHF. The diagnostic accuracy of NT-proBNP as quantified by the area under the receiver-operating characteristic curve was lower in obese versus non-obese patients (0.890 vs. 0.938). For rapid AHF rule-out in obese patients, the currently recommended cut-off of 300 pg/ml achieved a sensitivity of 96.7% (95% confidence interval [CI] 93.8-98.2%), ruling out 29% of patients and missing 9 AHF patients. For rapid AHF rule-in, the age-dependent cut-off concentrations (age <50 years 450 pg/ml; age 50-75 years 900 pg/ml; age >75 years 1800 pg/ml) achieved a specificity of 84.9% (95% CI 79.8-88.9%). Proportionally lowering the currently recommended cut-offs by BMI increased sensitivity to 98.2% (95% CI 95.8-99.2%), missing 5 AHF patients; reduced the proportion of AHF patients remaining in the 'gray zone' (48% vs. 26%; p = 0.002), achieving a specificity of 76.5% (95% CI 70.7-81.4%).

CONCLUSIONS:

Adjusting NT-proBNP concentrations for obesity seems to further increase its clinical utility in the early diagnosis of AHF.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido Natriurético Encefálico / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido Natriurético Encefálico / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Suiza